GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (XCNQ:CMND) » Definitions » PB Ratio

Clearmind Medicine (XCNQ:CMND) PB Ratio : 0.99 (As of Apr. 27, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Clearmind Medicine PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-27), Clearmind Medicine's share price is C$1.60. Clearmind Medicine's Book Value per Share for the quarter that ended in Oct. 2023 was C$1.62. Hence, Clearmind Medicine's PB Ratio of today is 0.99.

The historical rank and industry rank for Clearmind Medicine's PB Ratio or its related term are showing as below:

XCNQ:CMND' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 146.62
Current: 0.99

During the past 7 years, Clearmind Medicine's highest PB Ratio was 146.62. The lowest was 0.00. And the median was 0.00.

XCNQ:CMND's PB Ratio is ranked better than
79.76% of 1309 companies
in the Biotechnology industry
Industry Median: 2.38 vs XCNQ:CMND: 0.99

During the past 3 years, the average Book Value Per Share Growth Rate was -58.90% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Clearmind Medicine was 81.10% per year. The lowest was -58.90% per year. And the median was 11.10% per year.

Back to Basics: PB Ratio


Clearmind Medicine PB Ratio Historical Data

The historical data trend for Clearmind Medicine's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine PB Ratio Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
PB Ratio
Get a 7-Day Free Trial 6.62 7.13 5.63 - 2.78

Clearmind Medicine Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.51 1.59 1.51 2.78

Competitive Comparison of Clearmind Medicine's PB Ratio

For the Biotechnology subindustry, Clearmind Medicine's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's PB Ratio distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's PB Ratio falls into.



Clearmind Medicine PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Clearmind Medicine's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Oct. 2023)
=1.60/1.619
=0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Clearmind Medicine  (XCNQ:CMND) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Clearmind Medicine PB Ratio Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (XCNQ:CMND) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.